Hamilton Thorne CRH
Hamilton Thorne CRH is a global leader in Assisted Reproductive Technology (ART), providing consumables and equipment for in-vitro fertilization (IVF) procedures to hospitals, specialized clinics, and IVF laboratories across more than 115 countries.
Hamilton Thorne CRH was established in 2024 via two primary transactions: the carve-out of Cook Medical's Reproductive Health portfolio and the take-private of Hamilton Thorne Ltd.
In January 2025, Hamilton Thorne CRH signed the acquisition of Irvine Scientific's Reproductive Health assets, expanding its portfolio to vitrification and embryo culture media. The combined group offers a comprehensive range of high-quality and innovative ART products that improve the outcomes and accessibility of fertility treatments globally.
